Tor Gjøen

Image of Tor Gjøen
Norwegian version of this page
Phone +47 22844943
Mobile phone +47 95163161 +4795163161
Room 273 ZEB building
Visiting address Sem Sælands vei 3 Farmasibygningen 0371 OSLO
Postal address Postboks 1068 Blindern 0316 OSLO

Academic Interests

Our group studies interactions between intracellular parasites (mainly viruses) and host cells. Our main model systems are infectious pancreatic disease virus (IPNV) and infectious salmon anemia virus (ISAV), using cultured cells from Atlantic salmon. Using genomic (transcriptional analyses), biochemical (protein expression) and morphological analyses (fluorescence and electron microscopy),  our goal is to obtain an deeper understanding of host-pathogen interactions that will be of relevance to development of new and more efficient viral vaccines. In addition we study the effects on immune function of replacing marine fish oils (a scarce resource) with plant oils (abundant) as a main feed ingredients in finfish quaculture.


5 -year masters program in pharmacy:

Higher education and employment history

  • Professor,  Department of Pharmaceutical Biosciences, School of Pharmacy,  UiO, 2003 – present
  • Visiting scientist, The Scripps Research Institute, La Jolla, USA, 2004-2005
  • Ass.professor, Department of Pharmaceutical Biosciences, School of Pharmacy, UiO, 1996 -2003
  • Post.doc., Dept of Molecular biology, Institute of Biology,  UiO, 1993-1996
  • PhD student, Dept of Molecular biology, Institute of Biology , UiO, 1990-1993
  • Staff scientist, Dept of Pharmacology and Toxicology, Hafslund Nycomed, 1988-1989
  • PhD student , Institute for Medical biology, University of Tromsø, 1986-1987
  • Cand.scient, Physiology, Institute of Biology, UiO, 1986



Norwegian School of Veterinary Science


University of Reading

Department of Biosciences (IBV), UiO


Tags: Cell biology, Microbiology, Virus, Biotechnology, Immunology, Vaccine, Antibiotics, Molecular biology, Lipids, Life Science
Published Nov. 3, 2010 3:38 PM - Last modified May 29, 2018 11:50 AM